Literature DB >> 10692482

Allosteric interactions between the antagonist prazosin and amiloride analogs at the human alpha(1A)-adrenergic receptor.

R A Leppik1, A Mynett, S Lazareno, N J Birdsall.   

Abstract

It has been demonstrated previously that amilorides can interact with a well defined allosteric site on the human alpha(2A)-adrenergic receptor. In this study, the question was explored as to whether the human alpha(1A)-adrenergic receptor also possesses an equivalent allosteric site. The six amilorides examined strongly increased the dissociation rate of the antagonist [(3)H]prazosin from the alpha(1A)-adrenergic receptor in a concentration-dependent manner. With the parent amiloride, the dissociation data were well fitted by an equation derived from the ternary complex allosteric model, compatible with amiloride acting at a defined allosteric site on the alpha(1A)-adrenergic receptor. In contrast, the dissociation data for [(3)H]prazosin in the presence of the amiloride analogs were not compatible with the equation derived from a one-allosteric-site model, but could be fitted well by an equation derived from a two-allosteric-site model. However, certain individual parameters could not be resolved. The observed dissociation rate constants increased steeply with increasing amiloride analog concentration, and in some cases the data could be fitted with a logistic equation. The slope factors calculated from such fits were 1.2 to 2.1. It is concluded that the structure-binding relationships of the amilorides at the alpha(1A)- and alpha(2A)-adrenergic receptors are different. The interactions of the five amiloride analogs, but not the parent amiloride, with the alpha(1A)-adrenergic receptor are compatible with the presence of two (but not one) allosteric sites, and is thus more complex than that found for the alpha(2A)-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692482     DOI: 10.1124/mol.57.3.436

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.

Authors:  Z G Gao; J E Van Muijlwijk-Koezen; A Chen; C E Müller; A P Ijzerman; K A Jacobson
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

Review 2.  Structure-function of alpha1-adrenergic receptors.

Authors:  Dianne M Perez
Journal:  Biochem Pharmacol       Date:  2006-09-16       Impact factor: 5.858

3.  Maternal separation diminishes α-adrenergic receptor density and function in renal vasculature from male Wistar-Kyoto rats.

Authors:  Analia S Loria; Jeffrey L Osborn
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-22

4.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

Review 5.  Harnessing Ion-Binding Sites for GPCR Pharmacology.

Authors:  Barbara Zarzycka; Saheem A Zaidi; Bryan L Roth; Vsevolod Katritch
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

6.  Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors.

Authors:  Céline Rouget; Loïc Quinton; Arhamatoulaye Maïga; Céline Gales; Geoffrey Masuyer; Christian Malosse; Julia Chamot-Rooke; Robert Thai; Gilles Mourier; Edwin De Pauw; Nicolas Gilles; Denis Servent
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

7.  Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.

Authors:  Markus Kathmann; Karsten Flau; Agnes Redmer; Christian Tränkle; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-18       Impact factor: 3.000

8.  Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.

Authors:  Arhamatoulaye Maïga; Jon Merlin; Elodie Marcon; Céline Rouget; Maud Larregola; Bernard Gilquin; Carole Fruchart-Gaillard; Evelyne Lajeunesse; Charles Marchetti; Alain Lorphelin; Laurent Bellanger; Roger J Summers; Dana S Hutchinson; Bronwyn A Evans; Denis Servent; Nicolas Gilles
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

9.  A homotropic two-state model and auto-antagonism.

Authors:  Niels Bindslev
Journal:  BMC Pharmacol       Date:  2004-07-16

10.  Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.

Authors:  Thomas A Munro; Xi-Ping Huang; Carmela Inglese; Maria Grazia Perrone; Ashlee Van't Veer; F Ivy Carroll; Cécile Béguin; William A Carlezon; Nicola A Colabufo; Bruce M Cohen; Bryan L Roth
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.